MW Creators

World News

Hypoxic Ischemic Encephalopathy Market is Projected to Grow at a Healthy CAGR by 2030, States DelveInsight | Key Companies – Chiesi, ReAlta Life Sciences, Hope Biosciences, GW Pharma, and Others

DelveInsight’s “Hypoxic Ischemic Encephalopathy Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Hypoxic Ischemic Encephalopathy market trends in the seven major markets (7MM) (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The market report covers emerging drugs, current treatment practices, market share of the individual therapies, market drivers, barriers, unmet medical needs, current and forecasted market size from 2017 to 2030 segmented by seven major markets. 

Hypoxic Ischemic Encephalopathy Disease Overview

Hypoxic-ischemic encephalopathy (HIE) is a serious and life-threatening type of newborn brain damage (brain dysfunction) that occurs when the brain doesn’t receive enough oxygen and blood flow for a period of time. As the name suggests, Hypoxic means, not enough oxygen; ischemic means not enough blood flow; and encephalopathy means brain disorder.

It is vital to note that there is currently no approved treatment option for Hypoxic-Ischemic Encephalopathy. HIE is mainly managed using a treatment called therapeutic hypothermia, where the baby’s brain or body is cooled down below normal temperatures to slow the cascade effect that causes widespread damage.

Hypoxic Ischemic Encephalopathy Market Key Facts

  • As per the HIE Help Center, Neonatal HIE is estimated to occur in about 1.5 per 1,000 live births. Among infants with moderate HIE, 10-20% develop minor neurological conditions, and 30-50% develop more serious complications.
  • In a population-based study from January 2010 to December 2017 by Hage et al. (2021), 5201 babies with a diagnosis of HIE received TH or died; annual numbers increased over the study period. It was concluded that treatment with TH for HIE has increased in England, Scotland and Wales. An increasing proportion of treated infants have a diagnosis of mild HIE or have less severe clinical markers of hypoxia.
  • Neonatal encephalopathy due to birth asphyxia and trauma is the second leading cause of death in the first month of a child’s life. Close to half a million newborns died due to this condition in 2017.


Key Benefits of Hypoxic Ischemic Encephalopathy Market Report

  • The market report provides an in-depth analysis of Hypoxic Ischemic Encephalopathy Market size, share, and epidemiology in 7MM.
  • The report will help in developing business strategies by understanding the trends & developments, key players operating in the market, and future competition that will drive and shape the market outlook in the upcoming years.
  • The report covers the factors stimulating the Hypoxic Ischemic Encephalopathy market growth, current treatment practices, emerging drugs, market share of the individual therapies.
  • The report provides a detailed assessment of the patient population, unmet needs, comparative analysis of pipeline products with detailed clinical profiles, and other factors. 


Hypoxic Ischemic Encephalopathy Market

The Hypoxic Ischemic Encephalopathy market size is anticipated to increase in the coming years owing to the increase in R&D activity and rise in Hypoxic population in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Hypoxic Ischemic Encephalopathy market size and share by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology. 

The report gives a thorough detail of market trends, growth opportunities of each marketed and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Visit to get more detailed insights @

Hypoxic Ischemic Encephalopathy Epidemiology

The epidemiology section covers insights about historical and current Hypoxic Ischemic Encephalopathy patient pool and forecasted trends for every seven major markets from 2017 to 2030. It helps to recognize the causes of current and forecasted Hypoxic Ischemic Encephalopathy epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Discover more about the epidemiological segmentation @

Hypoxic Ischemic Encephalopathy Epidemiology Segmentation

  • Total incident Cases of Hypoxic Ischemic Encephalopathy 
  • Total incident cases of Hypoxic Ischemic Encephalopathy segmented by severity
  • Total treated cases of Hypoxic Ischemic Encephalopathy


Hypoxic Ischemic Encephalopathy Drugs Uptake and Key Market Players

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hypoxic Ischemic Encephalopathy market or expected to get launched in the market during the study period. The analysis covers the drug uptake; patient uptake by therapies; and sales of each drug.   

 Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Hypoxic Ischemic Encephalopathy Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent development such as collaborations, acquisitions, and mergers, licensing patent details, and other information.

Hypoxic Ischemic Encephalopathy Therapeutics Analysis

The dynamics of the Hypoxic Ischemic Encephalopathy (HIE) market are expected to improve in the coming years as a result of the increase in R&D activities and the introduction of new medicines.

Some of the key companies in the Hypoxic Ischemic Encephalopathy Market include:

  • Chiesi
  • ReAlta Life Sciences
  • Hope Biosciences
  • GW Pharmaceuticals

And others

Hypoxic Ischemic Encephalopathy Therapies covered in the report includes:

  • PIC1-dPEG24 (RLS-0071)
  • HB-adMSC
  • Intravenous CBD formulation

And many more

For further information about the emerging therapies and key companies @


Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Hypoxic Ischemic Encephalopathy Competitive Intelligence Analysis
  4. Hypoxic Ischemic Encephalopathy Market Overview at a Glance
  5. Hypoxic Ischemic Encephalopathy Disease Background and Overview
  6. Hypoxic Ischemic Encephalopathy Patient Journey
  7. Hypoxic Ischemic Encephalopathy Epidemiology and Patient Population
  8. Hypoxic Ischemic Encephalopathy Treatment Algorithm, Current Treatment, and Medical Practices
  9. Hypoxic Ischemic Encephalopathy Unmet Needs
  10. Key Endpoints of Hypoxic Ischemic Encephalopathy Treatment
  11. Hypoxic Ischemic Encephalopathy Marketed Products
  12. Hypoxic Ischemic Encephalopathy Emerging Therapies
  13. Hypoxic Ischemic Encephalopathy Seven Major Market Analysis
  14. Attribute Analysis
  15. Hypoxic Ischemic Encephalopathy Market Outlook (7 major markets)
  16. Hypoxic Ischemic Encephalopathy Access and Reimbursement Overview
  17. KOL Views on the Hypoxic Ischemic Encephalopathy Market.
  18. Hypoxic Ischemic Encephalopathy Market Drivers
  19. Hypoxic Ischemic Encephalopathy Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get a Free Sample Copy of the Report @

Latest Reports By DelveInsight:

Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Forecast

DelveInsight’s Hypoxic Ischemic Encephalopathy (HIE) – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Hypoxic Ischemic Encephalopathy (HIE) Pipeline Insight

“Hypoxic Ischemic Encephalopathy (HIE) Pipeline Insights, 2021” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across Hypoxic Ischemic Encephalopathy Market.

Malignant Pleural Mesothelioma (MPM) Market

DelveInsight’s Malignant Pleural Mesothelioma (MPM) – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the market size, share, trends, epidemiology, emerging therapies, and key companies in the domain.

Latest Healthcare Blogs By DelveInsight:


About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Info:
Shruti Thakur
DelveInsight Business Research LLP
Phone No: +91-9650213330
Email: [email protected]
Connect With Us: LinkedIn | Facebook | Twitter
For Latest Update: Healthcare Blog
Request for Sample Copy of the Report at:

Leave a Reply

Your email address will not be published. Required fields are marked *